Skip to main content
OpenTrials
Completed

NCT Number: NCT00171782

Hypertension and Cardiovascular Risk Factors

A study to evaluate the efficacy of valsartan+chydochlorothiazide in patients with stage 2 hypertension and cardiovascular risk factors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - Patients who give consent
  • Men and women 18 to 80 years of age
  • Patients with hypertension (systolic >159 mm, diastolic >100 mm)
  • Patients meeting laboratory criteria

Exclusion criteria

  • - Pregnant women
  • Women not using approved contraception methods
  • Secondary hypertension

Other protocol-defined exclusion criteria may apply.

Treatment and study plan

Valsartan+Hydrochlorothiazide

Drug

Primary outcomes

  1. Change from baseline systolic blood pressure at 8 weeks

Secondary outcomes

  1. Blood pressure less than 140/90 mmHg at 8 weeks

  2. Reduction from baseline in diastolic blood pressure greater than or equal to 10 mmHg

  3. Reduction from baseline in systolic blood pressure greater than or equal to 20 mmHg

Sponsors and collaborators

Lead sponsor

Novartis

Industry

Registry information

Official study title

Valsartan Plus Hydrochlorothiazide in Patients With Hypertension and Cardiovascular Risk Factors

Important dates

Study start
2004
Primary completion
2004
Study completion
2004
First posted
Sep 15, 2005
Registry last updated
Oct 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.